<DOC>
	<DOCNO>NCT00480649</DOCNO>
	<brief_summary>The primary study objective demonstrate clinical effectiveness SERETIDE therapy compare current care management moderate severe persistent asthma patient Korea .</brief_summary>
	<brief_title>Successful Control Clinical Effectiveness Of SERETIDE ( Salmeterol/Fluticasone Propionate ) Study In Asthma . ( SUCCESS )</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<mesh_term>Fluticasone Propionate , Salmeterol Xinafoate Drug Combination</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<criteria>Inclusion criterion : Male female subject age 18 year willing give write consent participate study . Subjects document clinical history reversible airway obstruction ( history take acceptable ) least 12 month , opinion investigator , able comply therapy complete Daily Record Cards ( DRCs ) correctly . Subjects able demonstrate ability effectively ( physically and/or mentally ) use DISKUS ( dummy DISKUS provide test ) . A female eligible enter participate study Subjects access telephone ( mobile landline home ) Exclusion criterion : Previous use ICS /LABA combination inhaler ( SYMBICORT ( Astrazeneca ) SERETIDE ) 12 week prior Visit 1 . Subjects know suspected hypersensitivity inhale steroid Beta2agonists . Subjects change regular asthma medication within 2 week Visit 1 . Subjects low respiratory tract infection within 4 week Visit 1 . Subjects smoke history 10 pack year ( e.g . 10 cigarettes/day 20 year 20 cigarettes/day 10 year 40 cigarettes/day 5 year ) time Visit 1 ( Current smoker include even his/her smoke history le 10 pack year time Visit 1 ) . Subjects suffer serious , uncontrolled disease ( include serious psychological disorder ) likely interfere study . Subjects immunotherapy Subjects take investigational drug within 4 week Visit 1 . Subjects , opinion investigator , evidence alcohol drug abuse . Females pregnant , lactate child bear potential likely become pregnant . Females childbearing age may include , opinion investigator , exert adequate contraceptive precaution . Subjects previously enrol study Patients regular oral parenteral steroid therapy last 4 week 3 course steroid last 6 month Subjects FEV1 PEFR le 50 % predictive value .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>SERETIDE</keyword>
	<keyword>asthma</keyword>
	<keyword>Korean</keyword>
	<keyword>ACT</keyword>
</DOC>